Evidence map›Paper›PMID 30517949›Full record

Observational studyMedical principles and practice : international journal of the Kuwait University, Health Science Centre2019

Over-the-Counter Herbal Weight Loss Supplements in Egypt: Label Claim, Microbiological and Pharmaceutical Quality, and Safety Assessments.

Nada Ahmed, Mohamed Ismail Nounou, Alaa Abouelfetouh, Amal El-Kamel

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Interpol review of controlled substances 2016-2019.Forensic science international. Synergy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Nada AhmedDepartment of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Mohamed Ismail NounouDepartment of Pharmaceutical Sciences, University of Saint Joseph, School of Pharmacy and Physician Assistant Studies (SPPAS), Hartford, Connecticut, USA, nounou@usj.edu.
Alaa AbouelfetouhDepartment of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Amal El-KamelDepartment of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Alexandria University · EGUniversity of Saint Joseph · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesNutraceuticals are advertised and sold with the label claim of being natural and safe herbal products. Due to the absence of clear regulations and guidelines for safety assessments of these products, nutraceuticals are commonly adulterated in order to increase sales. The objective of the current study was to design a comprehensive evaluation system to assess the safety, efficacy, authenticity according to label claim, and pharmaceutical quality of herbal slimming products in between 2015 and 2017.

methodsWe designed a comprehensive assessment system to evaluate the safety, authenticity according to label claim, and pharmaceutical quality of slimming nutraceuticals. Six different popular products were evaluated (Zotreem Plus®, Zotreem Extra®, Malaysian Super Slim®, AB Slim®, Chinese Super Slim®, and Metabolites®). The pharmaceutical evaluation included analyzing the samples via high-performance liquid chromatography to determine any possible adulterants. Additionally, the products' physical properties were assessed via pharmacopeial tests. Finally, a microbial evaluation and a cross-sectional observational retrospective prevalence study were conducted to assess the products' safety and efficacy. -Results: The tested products were found to be adulterated with unreported active pharmaceutical ingredients such as sibutramine, sildenafil, phenolphthalein, and orlistat. Furthermore, they contained heterogeneous amounts of adulterants and exhibited an unsatisfactory pharmaceutical and microbial quality. Finally, the observational survey conducted on users showed that high percentages of participants suffered from common side effects such as depression, diarrhea, and hypertension.

conclusionsThese products threaten the health of consumers. There is a need to raise awareness of the lethal consequences of illegal nutraceuticals.

Indexed as

Anti-Obesity AgentsAppetite DepressantsCross-Sectional StudiesDietary SupplementsDrugs, Chinese HerbalEgyptHumansNonprescription DrugsWeight LossAnti-Obesity AgentsAppetite DepressantsDrugs, Chinese HerbalNonprescription DrugsAB SlimAdulterationHerbal supplementsNutraceuticalsRetrospective prevalenceSibutramineSildenafilSterility test

Identifiers

PMID30517949
PMCPMC6545915
OpenAlexW2903228742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.